Stay updated with breaking news from Nasdaq Frln. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Freeline Therapeutics Holdings plc (NASDAQ:FRLN – Get Free Report) was the recipient of a large drop in short interest in December. As of December 15th, there was short interest totalling 51,400 shares, a drop of 35.3% from the November 30th total of 79,500 shares. Based on an average daily volume of 220,800 shares, the days-to-cover […]
Freeline Therapeutics Holdings plc (NASDAQ:FRLN – Get Free Report) was the target of a large decline in short interest in December. As of December 15th, there was short interest totalling 51,400 shares, a decline of 35.3% from the November 30th total of 79,500 shares. Based on an average daily trading volume, of 220,800 shares, the […]
Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual...
Wedbush reaffirmed their outperform rating on shares of Freeline Therapeutics (NASDAQ:FRLN – Free Report) in a report issued on Wednesday, RTT News reports. They currently have a $8.00 target price on the stock, up from their previous target price of $5.00. Separately, HC Wainwright reissued a buy rating and issued a $15.00 target price on […]
CHI Advisors LLC cut its holdings in Freeline Therapeutics Holdings plc (NASDAQ:FRLN – Free Report) by 1.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 4,729,419 shares of the company’s stock after selling 85,000 shares during the period. Freeline Therapeutics comprises approximately 0.6% of CHI Advisors […]